Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Polycythemia Vera CancerCare Connect Education Workshops - Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

05/13/21 • 61 min

Polycythemia Vera CancerCare Connect Education Workshops
* What is Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation? * Understanding How GVHD Develops * Finding GVHD Early, in the Context of COVID-19 * Common Signs & Symptoms of GVHD * Types of GVHD: Chronic and Acute * Current Standard of Care for Managing GVHD * New & Promising Treatment Approaches for GVHD * Clinical Trials Updates * How Research Increases Treatment Options * Key Questions to Ask Your Health Care Team about GVHD * Follow-Up Care Appointments * Communicating with Your Health Care Team about Your Quality-of-Life Concerns * Guidelines to Prepare for Telehealth/Telemedicine Appointment, including Technology & List of Questions * Questions for Our Panel of Experts
plus icon
bookmark
* What is Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation? * Understanding How GVHD Develops * Finding GVHD Early, in the Context of COVID-19 * Common Signs & Symptoms of GVHD * Types of GVHD: Chronic and Acute * Current Standard of Care for Managing GVHD * New & Promising Treatment Approaches for GVHD * Clinical Trials Updates * How Research Increases Treatment Options * Key Questions to Ask Your Health Care Team about GVHD * Follow-Up Care Appointments * Communicating with Your Health Care Team about Your Quality-of-Life Concerns * Guidelines to Prepare for Telehealth/Telemedicine Appointment, including Technology & List of Questions * Questions for Our Panel of Experts

Previous Episode

undefined - Update on CAR T-Cell Therapies

Update on CAR T-Cell Therapies

* Overview of CAR T-Cell Therapies, in the Context of COVID-19 * Understanding CARs - Chimeric Antigen Receptors * When to Consider CAR T-Cell Therapies as a Treatment Choice * Clinical Trials for CAR T-Cell Therapies * Discussion of CAR T-Cell Therapies * Managing Potential Treatment Side Effects * Specific Examples of How CAR T-Cell Therapies Contributes to Oncology Care * Key Questions to Ask Your Health Care Team about CAR T-Cell Therapies * The Benefits of CAR T-Cell Therapies * Follow-Up Care: What to Expect * Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & List of Questions * Questions for Our Panel of Experts

Next Episode

undefined - What’s New in Diagnostic Technologies for People Living with Solid Cancer Tumors

What’s New in Diagnostic Technologies for People Living with Solid Cancer Tumors

* Definition of Diagnostic Technologies for People Living with Solid Cancer Tumors, in the Context of COVID-19 * How Diagnostic Technologies Work & Are Used * Examples of How Diagnostic Technologies Inform/Transform the Treatment of Solid Cancer Tumors * Predicting Hereditary Risk * Diagnostic Technologies, Targeted Therapies & Precision Medicine * Clinical Trial Updates, in the Context of COVID-19 * Their Benefits * Current Application for People Living with Solid Cancer Tumors * The Increasing Role of Telehealth/Telemedicine Appointments, in the Context of COVID-19 * Questions for Our Panel of Experts

Episode Comments

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/polycythemia-vera-cancercare-connect-education-workshops-26015/life-with-graft-vs-host-disease-gvhd-post-allogeneic-stem-cell-or-bone-18522655"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to life with graft vs. host disease (gvhd) post allogeneic stem cell or bone marrow transplantation: new treatment approaches on goodpods" style="width: 225px" /> </a>

Copy